PortfoliosLab logo

AcelRx Pharmaceuticals, Inc. (ACRX)

Equity · Currency in USD · Last updated Mar 22, 2023

Share Price Chart

Loading data...


The chart shows the growth of $10,000 invested in AcelRx Pharmaceuticals, Inc. in Oct 2022 and compares it to the S&P 500 index or another benchmark. It would be worth nearly $76 for a total return of roughly -99.24%. All prices are adjusted for splits and dividends.

ACRX (AcelRx Pharmaceuticals, Inc.)
Benchmark (^GSPC)

S&P 500

Compare to other instruments

Search for stocks, ETFs, and funds to compare with ACRX

AcelRx Pharmaceuticals, Inc.


AcelRx Pharmaceuticals, Inc. had a return of -69.47% year-to-date (YTD) and -89.10% in the last 12 months. Over the past 10 years, AcelRx Pharmaceuticals, Inc. had an annualized return of -39.64%, while the S&P 500 had an annualized return of 9.77%, indicating that AcelRx Pharmaceuticals, Inc. did not perform as well as the benchmark.

1 month-55.48%-1.87%
6 months-86.58%2.64%
1 year-89.10%-10.31%
5 years (annualized)-56.01%7.81%
10 years (annualized)-39.64%9.77%

Monthly Returns Heatmap


Sharpe Ratio Chart

The Sharpe ratio shows whether the portfolio's excess returns are due to smart investment decisions or a result of taking a higher risk. The higher a portfolio's Sharpe ratio, the better its risk-adjusted performance.

The current AcelRx Pharmaceuticals, Inc. Sharpe ratio is -0.78. A negative Sharpe ratio means that the risk-free rate is higher than the portfolio's return. This value does not convey any meaningful information.

The chart below displays rolling 12-month Sharpe Ratio.

ACRX (AcelRx Pharmaceuticals, Inc.)
Benchmark (^GSPC)

Dividend History

AcelRx Pharmaceuticals, Inc. doesn't pay dividends

Drawdowns Chart

The Drawdowns chart displays portfolio losses from any high point along the way.

ACRX (AcelRx Pharmaceuticals, Inc.)
Benchmark (^GSPC)

Worst Drawdowns

The table below shows the maximum drawdowns of the AcelRx Pharmaceuticals, Inc.. A maximum drawdown is an indicator of risk. It shows a reduction in portfolio value from its maximum due to a series of losing trades.

The maximum drawdown since January 2010 for the AcelRx Pharmaceuticals, Inc. is 99.78%, recorded on Mar 20, 2023. The portfolio has not recovered from it yet.



To Bottom


To Recover



-99.78%Jul 23, 20132431Mar 20, 2023
-60%Jun 1, 2011135Dec 30, 2011218Nov 26, 2012353
-33.63%Feb 14, 201146Apr 19, 201127May 27, 201173
-33.4%Nov 27, 20128Dec 6, 201229Jan 18, 201337
-21.97%Feb 14, 201323Mar 19, 201316Apr 11, 201339
-15.9%Jun 12, 201310Jun 25, 20135Jul 2, 201315
-10.99%May 17, 20133May 21, 20131May 22, 20134
-9.84%Jan 23, 201312Feb 7, 20134Feb 13, 201316
-9.76%Apr 24, 20136May 1, 20134May 7, 201310
-9.29%Apr 15, 20133Apr 17, 20134Apr 23, 20137

Volatility Chart

Current AcelRx Pharmaceuticals, Inc. volatility is 195.83%. The chart below shows the rolling 10-day volatility. Volatility is a statistical measure showing how big price swings are in either direction. The higher asset volatility, the riskier it is, because the price movements are less predictable.

ACRX (AcelRx Pharmaceuticals, Inc.)
Benchmark (^GSPC)